Anti-oxidative and anti-inflammatory properties of xanthorrhizol in airway inflammation
Journal of Basic and Applied Pharmacology · 22.09.2026
DOI: 10.14456/jbap.2022.9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Basic and Applied Pharmacology, erschienen am 22.09.2026. Verfasst von Wai Shiu Fred Wong.
Abstract (Originalsprache)
Inflammation and oxidative damage contribute to the pathogenesis of chronic pulmonary diseases. Xanthorrhizol (XNT), a natural sesquiterpenoid from Curcuma xanthorrhiza, has been shown to have anti-microbial, anti-oxidative and anti-inflammatory properties. The present study evaluated the anti-oxidative and anti-inflammatory activities of XNT in various cell-free and cell culture models. XNT was found to possess a moderate free radical-scavenging capability using 2, 2-diphenyl-1-picrylhydrazyl (DPPH) cell-free assay, whose potency is lower than, but efficacy is comparable to the FDA-approved antioxidant agent trolox. In aeroallergen house dust mite (HDM)- and lipopolysaccharide (LPS)-stimulated Raw 264.7 macrophage cell line, XNT down-regulated both mRNA expression and protein production of proinflammatory cytokines and chemokines including TNF-α, IL-1β, IL-6, GM-CSF, etc. In addition, XNT was able to directly activate multiple antioxidant genes such as Hmox1 (Hemoxygenase-1), Nqo1 (NADPH quinone oxidoreductase-1), Gsr (glutathione reductase), and Gpx1 (glutathione peroxidase 1) in Raw 264.7 cell line. Furthermore, XNT suppressed corticosteroid-resistant cytokine IL-27 and IL-6 production in mouse primary alveolar macrophages upon combined LPS/IFN-γ stimulation, which implicates a severe subtype of asthma. Particularly, by combining cell surface markers with intracellular cytokine staining strategy, it was shown, for the first time that XNT decreased Th2/Th17 cytokine IL-5-, IL-13- and IL-17-expressing CD4 T cell frequency in single cell suspension isolated from HDM- and aspergillus fumigatus (AF)-exposed mouse lungs. Taken together, our findings reveal novel anti-oxidative and anti-inflammatory properties of XNT and implicate a new potential treatment to chronic pulmonary diseases.
Schlagwörter
Zitieren
APA
Wong, W. S. F. (2026). Anti-oxidative and anti-inflammatory properties of xanthorrhizol in airway inflammation. Journal of Basic and Applied Pharmacology. https://doi.org/10.14456/jbap.2022.9
Vancouver
Wong WSF. Anti-oxidative and anti-inflammatory properties of xanthorrhizol in airway inflammation. Journal of Basic and Applied Pharmacology. 2026. doi:10.14456/jbap.2022.9
BibTeX
@article{Wong2026,
author = {Wong, Wai Shiu Fred},
title = {Anti-oxidative and anti-inflammatory properties of xanthorrhizol in airway inflammation},
journal = {Journal of Basic and Applied Pharmacology},
year = {2026},
doi = {10.14456/jbap.2022.9}
}
EUVIMED